載入中
NASDAQHealthcareMedical - Healthcare Information Services
最新資料
US$0.422
−US$0.0104 · -2.41%
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
前收盤價
US$0.422
−US$0.0104 · -2.41%
盤中時間採用ET。市場資料可能有所延遲。
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
日內區間
目前US$0.422
52週區間
目前US$0.422
盤中時間採用ET。市場資料可能有所延遲。
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
日內區間
目前US$0.422
52週區間
目前US$0.422
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 45.6萬 USD | 61.59萬 USD | 73.15萬 USD | 8939 USD | — |
| 銷貨成本 | 20.56萬 USD | 23.59萬 USD | 30萬 USD | 4089 USD | — |
| 毛利 | 25.04萬 USD | 38萬 USD | 43.15萬 USD | 4850 USD | — |
| 銷售、一般及管理費用 | 1672.15萬 USD | 789.82萬 USD | 541.69萬 USD | 199.64萬 USD | 1.75萬 USD |
| 營業費用 | 1940.54萬 USD | 835.2萬 USD | 965.04萬 USD | 199.64萬 USD | 1.75萬 USD |
| 利息收入 | — | — | 6473 USD | — | — |
| 利息支出 | 10.35萬 USD | 1.37萬 USD | — | 6473 USD | 181 USD |
| 折舊和攤銷 | 172.42萬 USD | 73.15萬 USD | 2.49萬 USD | 3863 USD | — |
| 營業利益 | −1915.5萬 USD | −797.2萬 USD | −921.89萬 USD | −199.16萬 USD | −1.75萬 USD |
| 淨利 | −2064.35萬 USD | −870.6萬 USD | −921.24萬 USD | −199.81萬 USD | −1.77萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
